<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0020630" disease_type="Disease or Syndrome" abbrv="">Hypophosphatasia</z:e> (HPP) is an <z:e sem="disease" ids="C0025521" disease_type="Disease or Syndrome" abbrv="">inborn error of metabolism</z:e> characterized by defective bone mineralization caused by a deficiency in alkaline phosphatase (ALP) activity due to mutations in the tissue-nonspecific ALP (TNALP) gene </plain></SENT>
<SENT sid="1" pm="."><plain>The clinical expression of the disease is variable </plain></SENT>
<SENT sid="2" pm="."><plain>Six forms of HPP are identified according to age at presentation and clinical features </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with the infantile form are <z:mpath ids='MPATH_458'>normal</z:mpath> at birth </plain></SENT>
<SENT sid="4" pm="."><plain>First symptoms appear within the first 6 months of life </plain></SENT>
<SENT sid="5" pm="."><plain>Along with skeletal findings, HPP patients may present with <z:hpo ids='HP_0003072'>hypercalcemia</z:hpo>, <z:hpo ids='HP_0001250'>seizures</z:hpo>, <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>, and <z:hpo ids='HP_0010444'>pulmonary insufficiency</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001250'>Seizures</z:hpo> in HPP are refractory to conventional <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> drugs, but are responsive to <z:chebi fb="5" ids="16709">pyridoxine</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Herein, we report a case of HPP who presented with <z:chebi fb="5" ids="16709">pyridoxine</z:chebi>-responsive <z:hpo ids='HP_0001250'>seizures</z:hpo> in the early neonatal period and was found to have <z:hpo ids='HP_0003072'>hypercalcemia</z:hpo>, skeletal demineralization and <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> </plain></SENT>
</text></document>